The intron sequences of the human L-type pyruvate kinase gene (PKLR) were determined by using primers selected from the known cDNA sequence. Oligonucleotide primers for these determined intron sequences were used to sequence the exons. When this technique was applied to the
Deficiency of the enzyme pyruvate kinase (PK) is the most common cause of hereditary nonspherocytic hemolytic anemia (1) . There are two PK-encoding genes in humans, PKLR (expressed in liver and erythrocytes) and PKM2 (expressed in muscle). Mutation of PKLR causes the erythrocyte enzyme deficiency and hemolytic anemia. PKLR has been cloned, and the sequence of the coding region has been published (2) . Tissue-specific promoters result in the formation of two different types of cDNAs, a cDNA that codes for the erythrocyte enzyme, designated R-type PK, and one that codes for the liver enzyme, the L-type PK.
Biochemical diagnosis of PK deficiency is sometimes difficult, particularly in the unborn (3) and in patients who are transfusion-dependent. Although anemia due to PK deficiency is due to mutations of PKLR, the gene product of PKM2 is represented in leukocytes and may, therefore, obfuscate the diagnosis; it is not known which of the two genes are expressed in fetal cells. Moreover, hemolytic anemia may be from an abnormal PK that appears to have normal or even increased (4) activity under artificial in vitro assay conditions but that actually has functional abnormalities in substrate affinity or in its allosteric site for fructose diphosphate.
Although the sequence of the cDNA has been known for 4 yr (2), only three mutations causing hemolytic anemia have been elucidated (5) (6) (7) (8) . Rapid identification of mutations on the DNA level by PCR-based technology would be very useful but require determination of the appropriate intron sequences, which we now document. We show that primers hybridizing to these sequences can be used with the PCR to sequence the entire coding region of PK. Using this technology, we have found the putative disease-producing mutations in 16 alleles from 10 patients with PK deficiency.
MATERIALS AND METHODS
Patients. Ten unrelated patients with hemolytic anemia PK deficiency documented by assay of the erythrocyte enzymes (9) were investigated. The characteristics of these patients and the residual PK activity are summarized in Table 1 . Complete characterization of the samples according to recommended methods (10) was not done, but screening kinetics (9) were performed on most samples. For patient 4, the PK activity was only slightly below the normal range, but because the patient had a very young erythrocyte population, a much higher activity of the enzyme was expected. Accordingly, the patient was judged to be PK deficient; however, this diagnosis is not entirely certain.
Determination of Intron Sequences. Seven pairs of oligonucleotides based on the sequence ofTani et al. (2) were used to amplify segments of genomic DNA containing the introns by means of the PCR. Nested oligonucleotides were used, first to amplify single-stranded DNA and then to sequence the DNA, using the strategy we have outlined elsewhere for sequencing glucose-6-phosphate dehydrogenase (11) . The conditions of PCR were as follows: 94°C for 30 sec, 58°C for 30 sec, and 72°C for 30 sec. Intron 3 was an exception in that a lower annealing temperature (55°C) and a longer extension time (1 min) were used. The oligonucleotides used for amplification and sequencing of introns are shown in Table 2 .
Sequence Analysis of Exons. The oligonucleotides used for amplification and sequencing of exons are shown in Fig. 1 , and their use is summarized in Table 3 . The same PCR conditions and sequencing strategy (11) used to determine intron sequences were used to sequence the exons, except for the use of a 54°C annealing temperature for exon 1. Analysis for the polymorphic site at nt 1705, described by Kanno et al. (7) was done by amplifying an appropriate fragment by PCR and digesting with BspHI.
RESULTS AND DISCUSSION
Intron Sequences. The intron sequences flanking the 12 exons of the L-type PK gene are presented in Fig. 1 .
Mutation Analysis. Table 1 summarizes the findings in the 10 unrelated patients whose PKLR coding region was sequenced in its entirety. Surprisingly, a mutation at nt 1529 giving rise to an Arg -* Gln substitution in amino acid 510 was found in five of the patients and, indeed, in the homozygous form in patients 2 and 3. This mutation, thus, accounted for 7 of the 20 putative PK-deficient alleles, although all of the patients were, as far as we could determine, unrelated. The DNAs from 50 normal subjects were examined for this mutation with the restriction endonuclease Sty I. This mutation was not encountered in any of the 100 alleles represented in this sample. Because of this result and because no other nucleotide substitution was found in the coding region of these patients, it is unlikely that the A1529 mutation represents a polymorphism unrelated to the enzyme deficiency.
The mutation at nt 1529 represents a CpG -) CpA transition. Such mutations are favored (12) , probably because of the oxidation of methylated cytosine to thymine. Thus, a mutational hot spot could exist at this nucleotide. On the other hand, repeated occurrence of the same mutation sug-
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gests that it may represent a balanced polymorphism. We have previously raised the question of whether the heterozygous state for PK deficiency might offer some benefit to the carrier by virtue of elevated erythrocyte 2,3-bisphosphoglycerate levels and thereby reduced erythrocyte oxygen affimity (13) . The fact that the A1529 mutation was associated with a cytosine at the polymorphic site at nt 1705 in both patients 2 and 3 and that at least one cytosine was present in all of the other patients who were heterozygous for this mutation is entirely compatible with a single origin of this mutation. Determination of the haplotypes in which the A1529 mutation is found in additional patients with PK deficiency should allow us to distinguish between these alternatives.
Previously a C --T mutation at nt 1151 had been reported in two unrelated Japanese families (7, 14) and in a Lebanese family (5) . Although these findings suggested that this mutation might be the most prevalent PK mutation causing chronic hemolysis, the present data suggest that at least in Europeans the nt 1529 mutation predominates. The other mutations previously reported, C'26'-. A of PK Fukushima and PK Maebashi (7) and C47 --T of PK Linz (5), were not encountered in the present study.
In some instances no mutation could be found in the coding region. Although it is possible that such a mutation was present and was missed for technical reasons, it is more likely that some of these mutations represent substitutions in the promoter region or in splice sites. For patient 4, it is possible that the PK deficiency was not actually hereditary but rather was acquired (15) (16) (17) ; in this case, no mutation would be expected.
Discrepancies from the Publshed Sequence. Sequencing of the exons revealed four additional differences from the published sequence (2) . We found a thymine instead of an adenine at nt 388 [using the numbering system for the R-type PK cDNA (6) ]. The presence of a thymine at this position was verified by amplifying this portion of the gene by PCR with oligonucleotides 3'-GCTTGCAGGCCCTCCGCCAC-5' and 8F. Cleavage with Hinfl occurs if a thymine is present. All of 2F  1R  3F  2R  SF  4R  7F  6R  8F  7R  9F  8R   11F  1OR  12F  11R  14F  13R  1SF  14R  17F  16R  18F  17R   Amplifying  oligonucleotides   3R   3R  SR   9R   9R  9R  12R  12R  1SR  1SR  18R 18R Designations refer to the underlined sequences shown in Fig. 1 . The "coding" strand was amplified with the oligonucleotides ending in F; oligonucleotides ending in R were used to amplify the reverse strand. Although these differences could represent polymorphisms, when examined by restriction-endonuclease analysis of sequencing, these differences could not be found in 20-60 other alleles drawn from diverse populations. Therefore, they seem to represent cloning artifacts in the original sequence.
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Interestingly, in each case the nucleotide that we found is at a position at which a difference appears between human sequence and rat sequence; in each case the human sequence that we find is identical to the reported rat sequence (18) .
